PL366027A1 - Wydajny sposób wytwarzania inhibitora czynnika Xa - Google Patents

Wydajny sposób wytwarzania inhibitora czynnika Xa

Info

Publication number
PL366027A1
PL366027A1 PL01366027A PL36602701A PL366027A1 PL 366027 A1 PL366027 A1 PL 366027A1 PL 01366027 A PL01366027 A PL 01366027A PL 36602701 A PL36602701 A PL 36602701A PL 366027 A1 PL366027 A1 PL 366027A1
Authority
PL
Poland
Prior art keywords
inhibitor
factor
preparation
efficient process
efficient
Prior art date
Application number
PL01366027A
Other languages
English (en)
Inventor
Luigi Anzalone
Fuqiang Jin
David J. Meloni
Jung-Hui Sun
Christopher A. Teleha
Jia Cheng Zhou
Thomas E. Smyser
Hui-Yin Li
Original Assignee
Bristol-Myers Squibb Pharma Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Pharma Company filed Critical Bristol-Myers Squibb Pharma Company
Publication of PL366027A1 publication Critical patent/PL366027A1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL01366027A 2000-09-22 2001-09-12 Wydajny sposób wytwarzania inhibitora czynnika Xa PL366027A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23462200P 2000-09-22 2000-09-22
PCT/US2001/028406 WO2002024690A2 (en) 2000-09-22 2001-09-12 Efficient process for the preparation of a factor xa inhibitor

Publications (1)

Publication Number Publication Date
PL366027A1 true PL366027A1 (pl) 2005-01-24

Family

ID=22882119

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01366027A PL366027A1 (pl) 2000-09-22 2001-09-12 Wydajny sposób wytwarzania inhibitora czynnika Xa

Country Status (23)

Country Link
US (3) US6667332B2 (pl)
EP (1) EP1366045A2 (pl)
JP (1) JP2004529853A (pl)
KR (1) KR20040043089A (pl)
CN (1) CN1610679A (pl)
AU (1) AU2001292612A1 (pl)
BG (1) BG107813A (pl)
BR (1) BR0114102A (pl)
CA (1) CA2424576A1 (pl)
CZ (1) CZ2003835A3 (pl)
EE (1) EE200300116A (pl)
HR (1) HRP20030316A2 (pl)
HU (1) HUP0500133A2 (pl)
IL (1) IL155043A0 (pl)
IS (1) IS6754A (pl)
MX (1) MXPA03002493A (pl)
NO (1) NO20031308L (pl)
PL (1) PL366027A1 (pl)
RU (1) RU2003111464A (pl)
SK (1) SK4892003A3 (pl)
TW (1) TW593314B (pl)
WO (1) WO2002024690A2 (pl)
ZA (1) ZA200302971B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6339099B1 (en) * 1997-06-20 2002-01-15 Dupont Pharmaceuticals Company Guanidine mimics as factor Xa inhibitors
IL153378A0 (en) * 2000-07-18 2003-07-06 Bone Care Internat Inc STABILIZED 1alpha-HYDROXY VITAMIN D
TW200302225A (en) * 2001-12-04 2003-08-01 Bristol Myers Squibb Co Substituted amino methyl factor Xa inhibitors
AU2003270861A1 (en) * 2002-10-02 2004-04-23 Bristol-Myers Squibb Company Novel combination of a factor xa inhibitor and clopidogrel
WO2004041710A1 (ja) * 2002-11-06 2004-05-21 Matsushita Electric Industrial Co., Ltd. 変位検出機能を備えたマイクロアクチュエータ、および当該マイクロアクチュエータを備えた可変形ミラー
US7429581B2 (en) * 2002-12-23 2008-09-30 Sanofi-Aventis Deutschland Gmbh Pyrazole-derivatives as factor Xa inhibitors
US20050059719A1 (en) * 2003-09-16 2005-03-17 Badawy Sherif Ibrahim Farag Solid dosage formulation containing a Factor Xa inhibitor and method
MX2016011468A (es) 2014-03-07 2017-01-23 Biocryst Pharm Inc Inhibidores de calicreína plasmática humana.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020357A (en) * 1996-12-23 2000-02-01 Dupont Pharmaceuticals Company Nitrogen containing heteroaromatics as factor Xa inhibitors
ZA985247B (en) * 1997-06-19 1999-12-17 Du Pont Merck Pharma Guanidine mimics as factor Xa inhibitors.
US6339099B1 (en) * 1997-06-20 2002-01-15 Dupont Pharmaceuticals Company Guanidine mimics as factor Xa inhibitors

Also Published As

Publication number Publication date
TW593314B (en) 2004-06-21
CA2424576A1 (en) 2002-03-28
BG107813A (bg) 2004-01-30
ZA200302971B (en) 2005-05-09
NO20031308L (no) 2003-05-07
CN1610679A (zh) 2005-04-27
IS6754A (is) 2003-03-21
US20020061917A1 (en) 2002-05-23
IL155043A0 (en) 2003-10-31
WO2002024690A3 (en) 2003-09-25
AU2001292612A1 (en) 2002-04-02
NO20031308D0 (no) 2003-03-21
RU2003111464A (ru) 2004-10-27
BR0114102A (pt) 2005-04-19
MXPA03002493A (es) 2004-09-10
EP1366045A2 (en) 2003-12-03
HRP20030316A2 (en) 2005-02-28
EE200300116A (et) 2005-04-15
US20030212117A1 (en) 2003-11-13
WO2002024690A8 (en) 2002-08-08
US6747158B2 (en) 2004-06-08
CZ2003835A3 (cs) 2003-12-17
SK4892003A3 (en) 2004-04-06
US6667332B2 (en) 2003-12-23
US20040198787A1 (en) 2004-10-07
KR20040043089A (ko) 2004-05-22
JP2004529853A (ja) 2004-09-30
HUP0500133A2 (hu) 2005-04-28
WO2002024690A2 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
AU2001273040A1 (en) Factor xa inhibitors
PT1330370E (pt) Processo para o fabrico de elementos de superfície
HUP0402027A3 (en) Process for the preparation of a xantophyll
GB0025221D0 (en) New process
SG99351A1 (en) Process for the manufacture of a crystalline solid
HRP20040161A2 (en) Process for the preparation of a 14-hydroxynormorphinone derivative
PL366027A1 (pl) Wydajny sposób wytwarzania inhibitora czynnika Xa
PL350941A1 (en) Pyrazole-3-on-derivative as factor xa inhibitors
HK1048112B (zh) 3-乙烯基-頭孢化合物的製備方法
GB0031094D0 (en) New Process
HK1052350A1 (zh) 一種合成嗎啉基苯類化合物的新方法
GB0014546D0 (en) A novel process
GB0107062D0 (en) A mortar table
HK1051846A1 (en) A process for the purification of diacerein
HUP0300381A3 (en) New coupling process
GB0108017D0 (en) Process for the preparation of a catalyst
IL155189A0 (en) NOVEL CRYSTALLINE FORMS OF A FACTOR Xa INHIBITOR
GB0025940D0 (en) Solvogels & a method of manufacturing the same
GB0012448D0 (en) New process
AU141604S (en) A set of partition jointers
GB0105911D0 (en) Process for making a thrombon inhibitor
AU744296C (en) A process for the reduction of pterins
GB0003396D0 (en) A set of parts
GB0010572D0 (en) A set of parts
AU5600001A (en) Delamination process

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)